North Macedonia vs Serbia: Prevalence rate of hypertension in men aged 30-79
North Macedonia
49.4
in 2019
Serbia
49.9
in 2019
North Macedonia rank
13th
Serbia rank
10th
Prevalence rate of hypertension in men aged 30-79 over time
- North Macedonia
- Serbia
How they compare
Serbia currently reports 49.9 against 49.4 in North Macedonia, a difference of 0.5.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was North Macedonia ahead.
North Macedonia ranks 13th and Serbia ranks 10th of 195 countries.
Across the 3 decades both report, North Macedonia averaged higher in 2 and Serbia in 1.
Head to head by decade
| Decade | North Macedonia | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.18 | 47.75 | 0.43 | North Macedonia |
| 2000s | 48.52 | 48.32 | 0.2 | North Macedonia |
| 2010s | 49.32 | 49.56 | 0.24 | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, North Macedonia or Serbia?
- Serbia, at 49.9 against 49.4 in North Macedonia as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between North Macedonia and Serbia?
- 0.5, with Serbia ahead.
- How many years of comparable data are there for North Macedonia and Serbia?
- 30 years are reported by both, from 1990 to 2019.
- How do North Macedonia and Serbia rank globally for prevalence rate of hypertension in men aged 30-79?
- North Macedonia ranks 13th and Serbia ranks 10th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.